Sequoia Financial Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.38M Buy
80,753
+402
+0.5% +$34.2K 0.03% 308
2026
Q1
$6.92M Sell
80,351
-810
-1% -$72.7K 0.04% 265
2025
Q4
$7.09M Buy
81,161
+1,648
+2% +$125K 0.04% 257
2025
Q3
$4.55M Sell
79,513
-1,669
-2% -$96.1K 0.03% 318
2025
Q2
$4.79M Buy
81,182
+6,117
+8% +$395K 0.03% 286
2025
Q1
$5.49M Sell
75,065
-188
-0.2% -$15.5K 0.04% 256
2024
Q4
$6.22M Buy
75,253
+3,141
+4% +$248K 0.06% 231
2024
Q3
$5.16M Buy
72,112
+152
+0.2% +$10.7K 0.06% 214
2024
Q2
$4.93M Buy
71,960
+94
+0.1% +$5.62K 0.06% 193
2024
Q1
$3.85M Buy
71,866
+7
+0% +$376 0.05% 226
2023
Q4
$3.83M Sell
71,859
-619
-0.9% -$30.2K 0.05% 243
2023
Q3
$3.6M Buy
72,478
+797
+1% +$44.6K 0.06% 177
2023
Q2
$4.27M Buy
+71,681
New +$4.09M 0.07% 168

Other funds holding GMED

Sequoia Financial Advisors's GMED Position: Q2 2026 in Review

Sequoia Financial Advisors increased its Globus Medical (GMED) stake by 0.5% in Q2 2026, buying an estimated $34.2K and bringing the position to 80,753 shares worth $6.38M. The position accounts for 0.03% of the portfolio, ranked #308.

Sequoia Financial Advisors first reported a position in GMED in Q2 2023 and has held it in 13 quarters since. The position peaked at $7.09M in Q4 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Sequoia Financial Advisors held 80,753 shares of Globus Medical worth $6.38M as of Q2 2026.
  • Sequoia Financial Advisors bought 402 Globus Medical shares in Q2 2026, an estimated $34.2K.
  • Globus Medical made up 0.03% of Sequoia Financial Advisors's portfolio in Q2 2026, its #308 holding.
  • Sequoia Financial Advisors first reported a position in Globus Medical in Q2 2023 and has held it in 13 quarters since.
  • Sequoia Financial Advisors's Globus Medical position peaked at $7.09M in Q4 2025.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.